However, we have not tested the specific effect of IGF2BP2 on the accumulation of Aβ and phosphorylation of tau in AD mice, nor have we explored the complex regulatory network of IGFBP2 in modulating the development of AD. This evidence concerns the gene MAPT and Alzheimer disease.